特宝生物 (688278)

Xiamen Amoytop Biotech Co., Ltd.

KSH

Tags

SSE 380 IndexInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareGuozheng Growth IndexGene ConceptIntensive Research CoverageSmall Cap GrowthEmerging Markets IndexPrivate Enterprises 100 IndexWest Coast of the Taiwan StraitBiological ProductsSTAR Market 50 IndexSTAR Market Biotechnology IndexHigh-Performing StocksHepatitis ConceptEquity TransferMargin Trading and Securities Lending医药生物

K-Line Chart

No K-line data available

Company NameXiamen Amoytop Biotech Co., Ltd.
Listing Date2020-01-17
Issue Price8.24RMB
Registered Capital40818.94810k RMB
Legal RepresentativeSun Li
Registered AddressNo. 330 Wengjiao Road, Haicang Xinyang Industrial Zone, Xiamen City, Fujian Province, China
IndustryBiological Products
Main BusinessAn innovative biopharmaceutical enterprise engaged in the research and development, production, and sales of recombinant proteins and their long-acting modified drugs.
Company ProfileAmoytop Biotech is an innovative biopharmaceutical enterprise primarily engaged in the research and development, production, and sales of recombinant proteins and their long-acting modified drugs. The company focuses on immunology-related cytokine drugs as its main R&D direction, dedicated to providing better solutions for major diseases such as viral hepatitis and malignant tumors, as well as the field of immunotherapy. In the near future, the company will continue to concentrate on the field of chronic hepatitis B treatment, seeking breakthroughs in achieving clinical cure for chronic hepatitis B.

Stock Details

1. Key Indicators

  • Total Shares(W): 40818.95
  • Circulating A-Shares(W): 40818.95
  • Earnings Per Share(RMB): 1.6400
  • Net Assets Per Share(RMB): 7.3974
  • Operating Revenue(W RMB): 247954.79
  • Total Profit(W RMB): 73099.77
  • **Net Profit Attributable to Parent(W RMB) **: 66612.38
  • Net Profit Growth Rate(%): 20.21
  • Weighted Return on Equity(%): 23.8200
  • Operating Cash Flow Per Share(RMB): 1.1580
  • Undistributed Profit Per Share(RMB): 4.8287
  • Capital Reserve Per Share(RMB): 1.1191

2. Main Business

The main business covers:

  • Research, development, production and sales of recombinant proteins and their long-acting modified drugs

3. Company Basic Information

  • Company Name: Tebao Bio
  • Listing Date: Unknown
  • Industry: Unknown
  • Address: Unknown
  • Website: Unknown
  • Company Profile: Unknown

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
No Data No Data No Data No Data No Data

5. Concept Sectors

  • No Data

Remarks

  • Data update date: 2025-11-05
  • Data source: Public market information